Diagnostic enzymology
Enzymes are normally intracellular and LOW concentration in blood
Enzyme release (leakage)in the blood indicates cell damage (cell –death, hypoxia, intracellular toxicity)
Quantitative measure of cell/tissue damage
Organ specificity- but not absolute specificity inspite of same gene content.
Most enzymes are present in most cells-differing amounts
2. Measurement of serum enzymes
Diagnostic enzymology
Enzymes are normally intracellular and LOW concentration in blood
Enzyme release (leakage)in the blood indicates cell damage (cell –
death, hypoxia, intracellular toxicity)
Quantitative measure of cell/tissue damage
Organ specificity- but not absolute specificity inspite of same
gene content.
Most enzymes are present in most cells-differing amounts
3. Information from enzymes
measurements in serum
Presence of disease
Organs involved
Aetiology /nature of disease: differential diagnosis
Extent of disease-more damaged cells-more leaked enzymes in
blood
Time course of disease
5. Not enzymes
Now accepted as reliable markers for
myocardial infarction
3 subunits:-
1) Troponin T(TnT): Tropomyosin binding
elements
2) Troponin I(TnI): Actinomyosin ATPase
inhibitory elements
3)Troponin C(TnC): Calcium binding
6. Cardiac isoform of CTnT & CTnI:-
95% located in myofibrils &
5% cytoplasmic
TnT:- ↑ within 6 hrs of MI & remains ↑ up to 7-14
days.
TnI:- released into the blood within 4 hrs after the
onset of symptoms of myocardial ischemia; peaks
at 14-24 hrs & remains ↑ for 3-5 days post-
infarction.
Note:- cardiac troponin ↑ at lower conc. than the 99th percentile
value used for MI but still have a risk of having an adverse cardiac
event.
Troponin-I:- 1 – 10 µg/L
7. 1) H-FABP:-
Heart-type fatty acid binding protein
Kinetically similar to myoglobin but more
specific to cardiac tissue which contains a
greater percentage of this protein than skeletal
muscle
May also have role in prediction- prognosis in
patients with NSTEMI
Current studies ongoing to further evaluate its
utility
8. 2) Brain Natriuretic Peptide(BNP):-
Natriuretic peptide family consists of 3
peptides:-
a) atrial natriuretic peptide(ANP)
b) brain natriuretic peptide(BNP)
c) C-type natriuretic peptide(CNP)
ANP:-produced in cardiac atria.
9. BNP:-
present in human brain but more in cardiac
ventricles.
pro-BNP- 108A.As
High plasma conc. of ANP & BNP :- CHF
↑ BNP- COPD
pro-BNP:- best marker of ventricular dysfunction
10. Myeloperoxidase
• MPO is an enzyme that aids white blood cells in
destroying bacteria and viral particles
• MPO catalyzes the conversion of hydrogen
peroxide and chloride ions (Cl-) into hypochlorous
acid
• Hypochlorous acid is 50 times more potent in
microbial killing than hydrogen peroxide
• MPO is released in response to infection and
inflammation
• EPIC Norfolk Study showed its predictive value
for future cardiovascular disease events in
asymptomatic adults.
11. • MPO leads to oxidized LDL cholesterol
– Oxidized LDL is phagocytosed by macrophages
producing foam cells*
• MPO leads to the consumption of nitric oxide
– Vasoconstriction and endothelial dysfunction
• MPO can cause endothelial denuding and
superficial platelet aggregation
• MPO indicates activated immune cells
– Activated immune cells and inflammation lead to
unstable plaque*
• Inflammatory plaque is inherently less stable
– Thin fibrous cap/fissured/denuded
Brennan, NEJM 2003
*Hansson, NEJM 2005
12. Chronic inflammation also is an important
component in the development & progression of
atherosclerosis.
Numerous epidemiological studies have
demonstrated that ↑ serum CRP conc. are +vely
associated with a risk of future CHD events when
using an hsCRP assay.
Synthesis- LIVER
13. Single hs-CRP measurement is a stong predictor
of:-
a) MI
b) Stroke
c) Peripheral vascular disease
d) Sudden cardiac death:- individuals without a
history of heart disease.
Direct comparison of traditional and novel
biochemical markers of CHD risk, hsCRP is the
strongest predictor of future coronary events.
14.
15. Stefan Blankenberg, MD; Renate Schnabel, MD; Edith Lubos, MD, et al., Myeloperoxidase Early Indicator of Acute Coronary Syndrome and
Predictor of Future Cardiovascular Events 2005
18. Very much elevated in muscular dystrophies(500-1500 IU/L).
Female carriers of X-linked muscular dystrophy (heterozygous)
Raised values:-
Secondary muscle disease
Hypothyroidism
Crush injury
Fracture &
Cerebrovascular accidents.
Actual values depends on:-
Severity of the disease &
Mass of diseased muscle.
19. 2) AST :- not used now-a-days.
3) Aldolase:-
glycolytic enzyme
until recent years enzyme of choice
more sensitive than AST
Sites:- Liver, skeletal muscle & brain.
Also found in neoplastic tissues.
21. Non-specific enzymes
hydrolyses aliphatic, aromatic or heterocyclic
compounds.
optimum PH:- betn 9-10.
activated by magnesium & manganese.
Zn is a constituent ion of ALP.
22. Produced by osteoblasts of bone
associated with calcification process.
localised in cell membranes (ecto-enzyme)
Also associated with transport mechanisms in
liver, kidney & intestinal mucosa.
23. i) α1 – ALP:-
Synthesized by epithelial
cells of biliary canaliculi.
about 10% of total activity
↑ in obstructive jaundice.
ii) α2 – ALP:- heat labile
Stable at 56
o
C
Produced by hepatic cells
About 25% of total ALP
24. iii) α2 – ALP:- heat stable
not be destroyed at 65o
C
inhibited by Phenylalanine
placental origin:- found in blood in normal
pregnancy.
carcinoplacental iso-enzyme:- carcinoma of
lungs, liver & gut.
1% of ALP
25. iv) pre-β ALP:- heat labile
origin- bone
50% of normal ALP
↑ in bone diseases.
marker of bone disease
v) γ- ALP:-
origin- intestinal cells
inhibited by phenylalanine
↑ in ulcerative colitis.
10% of ALP
vi) Leukocyte- ALP:-
↑ in LYMPHOMA
↓ in CML
26. C) Drastically high levels:- 10-25 times of upper limit
bone diseases
Osteoblastic activity is enhanced such as paget’s disease,
rickets, osteomalacia, osteoblastoma, metastatic carcinoma of
bones & hyperparathyroidism.
A) Moderate ↑:- 2-3 times
Hepatic diseases such as infective hepatitis,
alcoholic hepatitis or hepatocellular carcinoma.
B) Very high:- 10-12 times
Extrahepatic obstruction (obs. Jaundice)
Intrahepatic cholestasis ( infective hepatitis
28. Produced from epithelium of prostate gland.
Normally secreted in to seminal fluid.
liquefaction of seminal coagulum.
serine protease & 32 Kd glycoprotein.
Blood- bound to α2-macro-globulin & α1 – antitrypsin.
very specific for prostate activity
Values above 10µg/L is indicates prostate cancer.
29. an important tumor marker
Secreted by prostate cells, RBC, Platelets & WBC.
Hydrolyses phosphoric acid ester at PH betn 4-6.
ACP of prostate is inhibited by L-tartrate i.e tartrate labile (1 U/L)
30. ↑ ed in prostate cancer & highly elevated in bone metastasis of prostate
cancer.
Marked ↑ in:-
○ Gaucher’s disease,
○ thrombocytosis,
○ chronic granulocytic leukaemia,
○ myeloproliferative disorders etc.
Occasional rise in:-
○ paget’s disease,
○ hyperparathyroidism &
○ osteolytic metastasis from breast & other carcinomas.
39. 2 types:-
1) True cholineesterase :-
(acetylcholine hydrolase &
acetyl-cholineesterase)
Present:- nerve tissue & RBC.
Function:- hydrolysis of acetylcholine at the synapses &
neuromuscular junction.
2) Pseudocholinesterase :-
(acetylcholine acyl-hydrolase &
Cholinesterase)
Present:- liver, heart muscle, intestine & sera.
Function:- not known
40. Clinical Significance:-
Liver function test
imp. Indicator of insecticide poisoning.
↓ in:-
Uremia, shock, anemia, cancer,
tuberculosis & malnutrition.
• Degrades succinylcholine, a muscle relaxant given during general
anesthesia in surgery.
• Some people are deficient in plasma cholinesterase (congenital
inherited recessive disease), so the normal dose of succinyl-choline
would kill them
Therefore, a determination of plasma cholinesterase is made
prior to major surgery.
44. The best six doctors anywhere
And no one can deny it
Are sunshine, water, rest, and air
Exercise and diet.
These six will gladly you attend
If only you are willing
Your mind they'll ease
Your will they'll mend
And charge you not a shilling.